MedicarePartD.guide

A non-government resource built from CMS public data

2026 HealthSpring Assurance Rx (PDP) formulary (drug list)

Contract S5617, plan 227 · Alaska · 3,188 drugs on file · formulary ID 00026089. Each drug links to its cost in every CMS PDP Region 34 plan.

Hide drugs on tiers

32 drugs starting with K.

Drug nameTier30-day preferred pharmacy90-day mail orderUsage management
KAITLIB FE KitNorethindrone And Ethinyl Estradiol4Non-Preferred Drug29%29%None
KALETRA 80/20 mg/mL SolutionLopinavir And Ritonavir4Non-Preferred Drug29%29%None
KALYDECO 150 mg Tablet, Film CoatedIvacaftor5Specialty Tier25%N/A
  • PA
  • QL 56 per 28 days
KARIVA KitDesogestrel/Ethinyl Estradiol And Ethinyl Estradiol4Non-Preferred Drug29%29%None
KELNOR 1/35 KitEthynodiol Diacetate And Ethinyl Estradiol4Non-Preferred Drug29%29%None
KERENDIA 10 mg Tablet, Film CoatedFinerenone3Preferred Brand25%25%
  • PA
  • QL 3 per 30 days
KERENDIA 20 mg Tablet, Film CoatedFinerenone3Preferred Brand25%25%
  • PA
  • QL 3 per 30 days
KERENDIA 40 mg TabletFinerenone3Preferred Brand25%25%
  • PA
  • QL 3 per 30 days
KESIMPTA 20 mg/.4mL Injection, SolutionOfatumumab5Specialty Tier25%N/A
  • PA
  • QL 1.6 per 28 days
KETOCONAZOLE 20 mg/g CreamKetoconazole Cream, 2%2Generic10%10%
  • QL 6 per 28 days
KETOCONAZOLE 20 mg/mL Shampoo, Suspension2Generic10%10%
  • QL 12 per 28 days
KETOCONAZOLE 200 mg Tablet3Preferred Brand25%25%None
KETOROLAC TROMETHAMINE 4 mg/mL Solution/ Drops3Preferred Brand25%25%None
KETOROLAC TROMETHAMINE 5 mg/mL Solution2Generic10%10%None
KINERET 100 mg/.67mL Injection, SolutionAnakinra5Specialty Tier25%N/A
  • PA
  • QL 20.1 per 30 days
KINRIX 25/10/25/8/25/40/8/32 [iU]/.5mL/ug/.5mL Injection, SuspensionDiphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed And Inactivated Poliovirus Vaccine3Preferred Brand25%25%None
KISQALI 200 mg Tablet, Film CoatedRibociclib5Specialty Tier25%N/A
  • PA
  • QL 21 per 28 days
KISQALI 200 mg Tablet, Film CoatedRibociclib5Specialty Tier25%N/A
  • PA
  • QL 42 per 28 days
KISQALI 200 mg Tablet, Film CoatedRibociclib5Specialty Tier25%N/A
  • PA
  • QL 63 per 28 days
KLISYRI 10 mg/g OintmentTirbanibulin4Non-Preferred Drug29%29%
  • ST
  • QL 5 per 30 days
KLOR-CON 1.5 g Powder, For SolutionPotassium Chloride2Generic10%10%None
KLOR-CON 600 mg Tablet, Film Coated, Extended ReleasePotassium Chloride2Generic10%10%None
KLOR-CON 750 mg Tablet, Film Coated, Extended ReleasePotassium Chloride2Generic10%10%None
KLOR-CON M 1500 mg Tablet, Extended ReleasePotassium Chloride2Generic10%10%None
KLOR-CON M 750 mg Tablet, Extended ReleasePotassium Chloride2Generic10%10%None
KLOXXADO 8 mg/.1mL SprayNaloxone Hcl3Preferred Brand25%25%None
KOSELUGO 10 mg CapsuleSelumetinib5Specialty Tier25%N/A
  • PA
  • QL 24 per 30 days
KOSELUGO 25 mg CapsuleSelumetinib5Specialty Tier25%N/A
  • PA
  • QL 12 per 30 days
KOSELUGO 5 mg GranuleSelumetinib5Specialty Tier25%N/A
  • PA
KOSELUGO 7.5 mg GranuleSelumetinib5Specialty Tier25%N/A
  • PA
KRAZATI 200 mg Tablet, CoatedAdagrasib5Specialty Tier25%N/A
  • PA
  • QL 18 per 30 days
KURVELO KitLevonorgestrel And Ethinyl Estradiol4Non-Preferred Drug29%29%None

PA = prior authorization, ST = step therapy, QL = quantity limit. Costs are the plan’s initial-coverage cost-sharing from the CMS 2026 formulary files; a drug not listed here is not on this plan’s formulary, though a formulary exception may still be possible.